$1,670,000 of THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to prior authorization. S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) including in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA); Issues relating to implementation of the No Surprises Act. H.R. 3838/S. 2296 Pharmacy issues related to the National Defense Authorization Act, FY2026. "S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act." Issues related to the specialty drug market. Issues related to transparency. Issues related to competition in the health care marketplace."
You can find more data on corporate lobbying on Quiver Quantitative.
CI Congressional Stock Trading
Members of Congress have traded $CI stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CI stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 12/19 and 2 sales worth up to $30,000 on 03/13, 11/12.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CI Insider Trading Activity
CI insiders have traded $CI stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CI stock by insiders over the last 6 months:
- DAVID CORDANI (Chairman & CEO) purchased 4,134 shares for an estimated $999,916
- NICOLE S JONES (See Remarks) sold 2,307 shares for an estimated $666,515
- EVERETT NEVILLE (See Remarks) sold 1,719 shares for an estimated $496,636
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CI Hedge Fund Activity
We have seen 697 institutional investors add shares of CI stock to their portfolio, and 742 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 6,882,711 shares (-74.7%) from their portfolio in Q4 2025, for an estimated $1,894,328,548
- PRICE T ROWE ASSOCIATES INC /MD/ removed 5,032,153 shares (-44.5%) from their portfolio in Q4 2025, for an estimated $1,384,999,470
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 3,738,636 shares (-99.9%) from their portfolio in Q4 2025, for an estimated $1,028,984,786
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 3,141,844 shares (+13333.2%) to their portfolio in Q4 2025, for an estimated $864,729,724
- DODGE & COX added 1,833,389 shares (+19.7%) to their portfolio in Q4 2025, for an estimated $504,603,654
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,245,656 shares (-39.2%) from their portfolio in Q4 2025, for an estimated $342,841,900
- BOSTON PARTNERS added 1,243,056 shares (+314.6%) to their portfolio in Q4 2025, for an estimated $342,126,302
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CI Analyst Ratings
Wall Street analysts have issued reports on $CI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 02/02/2026
- Truist Securities issued a "Buy" rating on 01/05/2026
- Goldman Sachs issued a "Buy" rating on 11/04/2025
- TD Cowen issued a "Buy" rating on 11/04/2025
To track analyst ratings and price targets for CI, check out Quiver Quantitative's $CI forecast page.
CI Price Targets
Multiple analysts have issued price targets for $CI recently. We have seen 11 analysts offer price targets for $CI in the last 6 months, with a median target of $334.0.
Here are some recent targets:
- David Windley from Jefferies set a target price of $330.0 on 04/20/2026
- Lance Wilkes from Bernstein set a target price of $358.0 on 03/12/2026
- Jessica Tassan from Piper Sandler set a target price of $370.0 on 03/03/2026
- David Macdonald from Truist Securities set a target price of $350.0 on 02/17/2026
- Charles Rhyee from TD Cowen set a target price of $338.0 on 02/09/2026
- Andrew Mok from Barclays set a target price of $303.0 on 02/06/2026
- Jason Cassorla from Guggenheim set a target price of $334.0 on 02/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
